Treating Mastitis Is Getting More Expensive. Here's the Math Your Clients Need to Hear.

Mastitis is the most common and most costly infectious disease in dairy cattle. Every dairy veterinarian knows that. But new research out of Michigan State University puts numbers to something that producers often underestimate: treating a single case of mastitis costs an average of $192 — and the biggest driver of that cost isn't the drugs. It's the milk you're throwing away.

Dr. Pamela Ruegg and her team analyzed more than 20,000 mastitis cases across 37 Wisconsin dairy farms over one year. The paper, published in the Journal of Dairy Science in 2023, breaks down what actually drives treatment costs at the farm level — and the findings have direct implications for how you counsel your dairy clients on treatment protocols.

Discarded Milk Costs More Than the Antibiotics

Of the average $192 partial direct cost per mastitis case, roughly 87% came from discarded milk — not from the drugs themselves. Antibiotics accounted for just 13% of the total.

87 cents of every dollar spent treating mastitis is milk you can't sell.

This matters because it reframes the conversation producers often have about mastitis treatment. When a farmer focuses on finding the cheapest antibiotic, they're optimizing the smaller piece of the problem. The larger lever is how long the cow is under treatment — and by extension, how long her milk is being discarded.

Today's high-producing dairy cows amplify this dynamic in ways that weren't as significant a generation ago. The researchers found that a cow producing 100 lbs. of milk per day costs approximately $174 to treat, while a cow producing 50 lbs. per day costs only $62. Same disease, same drug, very different economic outcome — purely because of milk yield.

Not All Cows Cost the Same to Treat

The research identified several cow-level factors that drive treatment cost variation — information that's directly useful when helping producers think through their protocols.

Parity matters. Older cows in their third or greater lactation cost an average of $196 per case, compared to $163 for first-lactation animals. The mechanism is straightforward: higher-parity cows produce more milk, so there's more to discard.

Recurrent cases are actually cheaper to treat. Cows experiencing a second or third mastitis case within the same lactation have often already had their milk yield reduced by prior infections. Less milk production means less discard cost, even though the clinical situation may be more complex.

Stage of lactation is a significant variable. Cows in peak lactation — roughly 60 to 120 days in milk — carry the highest partial direct treatment costs because their milk production is at its peak. The same case of mastitis diagnosed in late lactation costs less simply because the cow is producing less.

The Minimum Label Duration. Use It.

Here's the finding with the most direct clinical protocol implication: many producers in this study treated for the maximum label duration even though extended treatment was not associated with improved outcomes. The data showed that treating for the minimum label duration saves approximately $65 per case.

Sixty-five dollars sounds modest. Scale it up. In a 1,000-cow dairy with 333 mastitis cases per year — a reasonable incidence rate — that's $21,645 in annual savings on antibiotics and milk discard alone, without any compromise in treatment effectiveness.

$21,645 in savings per year. Same outcomes. Just minimum label duration instead of maximum.

The takeaway for your practice is clear: reviewing treatment duration protocols with your dairy clients is low-hanging fruit. Producers defaulting to maximum duration aren't getting better results — they're spending more money and discarding more milk without clinical justification. This is the kind of data-driven conversation that makes you valuable to a herd health program beyond just diagnosing and treating.

What to Do With This Information

Dr. Ruegg's research is a useful framework for the herd-level mastitis consultation. When you sit down with a producer to review treatment protocols, ask them to consider three things: which cows in their herd are generating the most treatment cost (high producers, higher-parity cows, peak lactation animals), whether their current antibiotic selection and duration is actually protocol-driven or habit-driven, and whether their milk discard practices are matching the actual label requirements rather than exceeding them.

Mastitis treatment is simultaneously an animal health decision and a business decision — and increasingly, your clients need you to help them make it as both. The economics of treating a 100-lb-per-day cow are fundamentally different from treating a 50-lb-per-day cow, and that calculation should be part of your protocol conversation.

The full research paper — Variation in partial direct costs of treating clinical mastitis among 37 Wisconsin dairy farms — was published in the Journal of Dairy Science in 2023. Dr. Ruegg's video series on the economic aspects of mastitis treatment is available on her YouTube channel for clients who want to go deeper on the data.

───────────────────────────────

Vet Candy covers clinical research, food animal medicine, and the science shaping veterinary practice. For NAVLE prep, CE, and career resources, visit myvetcandy.com.